FDA Approves New Drug for PrEP

October 4, 2019

The U.S. Food and Drug Administration today approved Gilead’s drug Descovy to be used as PrEP, a daily HIV prevention regimen that when taken properly makes it virtually impossible to contract the virus from someone living with the disease.